Actively Recruiting

Phase 3
Age: 19Years +
All Genders
ID06284876

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg Compared to Lansoprazole 15 mg in Preventing NSAIDs-Associated Peptic Ulcer A Multicenter, Randomized, Double-Blind, Active-Controlled Phase III Trial

Led by Il-Yang Pharm. Co., Ltd. ยท Updated on 2025-05-30

416

Participants Needed

2

Research Sites

135 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To demonstrate the non-inferiority of Ilaprazole 10 mg to the active control in prevention of NSAIDs-associated peptic ulcer, as assessed by the proportion of subjects with peptic ulcer by Week 24

CONDITIONS

Official Title

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  1. Adult males and females aged 19 years or older on the day of informed consent
  2. Subjects requiring continuous treatment or receiving treatment with NSAIDs
  3. Subjects with at least one of following peptic ulcer risk factors at the time of Screening
  4. Subjects who have provided voluntary informed consent for the study participation after the study is explained
Not Eligible

You will not qualify if you...

  1. Subjects with Gastroesophageal varices, Esophageal stricture or ulcerous stenosis, Gastrointestinal bleeding or perforation, Esophageal dysplasia and else based on the screening EGD results.
  2. Subjects with inflammatory bowel diseases, pancreatitis, pyloric obstruction, and primary esophageal motility disorder
  3. Subjects with confirmed history of malignancy within 5 years prior to Screening
  4. Positive human immunodeficiency virus (HIV) antigen/antibody at Screening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Chung Ang University Hospital

Seoul, South Korea

Actively Recruiting

2

Chung-Ang University Hospital

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

J

JungHwa Hong, Master

J

JeongSu Wi, bachelor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Treatment Study Comparing Regimens With and Without Bismuth ...

Helicobacter Pylori Infection

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here